Defence Therapeutics details impressive Accum™ patent portfolio
Leading biotechnology company Defence Therapeutics explores its growing patent portfolio for the company’s flagship AccumTM-based platform.
Defence Therapeutics is harnessing the power of AccumTM to...
Revolutionising the NHS: UK Government injects £21m for AI healthcare technology
The UK Government has announced it will fund £21m to roll out AI healthcare technology across the NHS.
Announced today by the Health and Social...
Pulsar Helium: Unmatched high-grade helium supply for the medical industry
With the helium shortage affecting MRI and respiratory gases, Pulsar Helium’s high-grade asset provides hope for the medical industry's helium supply.
Last year the American...
Defence’s Accum™ technology effectiveness shown in published patent application
Defence Therapeutics has announced the publication of its new international (PCT) patent application. This demonstrates the effectiveness of Defence’s Accum™-based technology to intracellularly deliver...
Cordyceps and CBD oil: A revolutionary partnership in health and wellness
In the contemporary era of health consciousness, holistic wellness, and the pursuit of natural remedies, two significant players have emerged: Cordyceps and CBD oil.
Cordyceps...
Defence Therapeutics has reached the final stages of AccuTOXTM for its phase I clinical...
Defence Therapeutics has announced that it has reached the final stages of its AccuTOXTM Chemistry, Manufacturing, and Controls (CMC).
A Canadian biopharmaceutical company specialised in...
Defence Therapeutics initiate testing of ARM vaccine against pancreatic cancer
Defence Therapeutics has mandated the Transbiotech Biotechnology Research and Transfer Center to begin testing its cellular anti-cancer ARM vaccine against pancreatic cancer.
Research from the...
How reishi mushrooms are dominating the French CBD market
For their numerous health advantages, reishi mushrooms have been used in traditional Chinese medicine for thousands of years.
This nootropic has recently gained popularity as...
Defence Therapeutics’ ARM vaccine cures 100% of solid tumours in rodent models
Defence Therapeutics has revealed that the company’s cutting-edge ARM vaccine cures 100% of tumours in rodent models.
The leading biopharmaceutical company revealed that performing a...
Ashwagandha and CBD oil: An in-depth look at their synergistic benefits
With the increasing interest in natural remedies, the therapeutic potential of ashwagandha and CBD oil has garnered significant attention.
These plant-based compounds boast unique health...
Can probiotics improve gut health?
Probiotics are a key way to support the digestive system and have the potential to offer many benefits for those aiming to improve their...
A boost for NervGen’s spinal cord injury trials
Following the success of its phase I clinical trial, NervGen will initiate a phase Ib/IIa trial as early as Q3 this year to demonstrate...
Defence Therapeutics completes AccuTOXTM preclinical efficacy studies
Defence Therapeutics has successfully completed all essential preclinical efficacy studies for the company’s AccuTOXTM programme.
AccuTOXTM is one of Defence’s most advanced research and development...
Pioneering approaches to gynaecological cancer diagnostics
Lorna Rothery spoke to Marina Rigau, CEO and Co-Founder of EIT Health-supported start-up MiMARK, about the challenges associated with the diagnosis of gynaecological conditions.
By...
How to tackle social care recruitment challenges
Laura Wolstenholme, Head of Workforce at Persona Care and Support, outlines the importance of training opportunities within the social care sector.
Recruitment and retention challenges...
Emergency care at crisis point
Long-established issues in the health system are being reflected in emergency care, bold actions are needed to address this.
Making rare disease medicines less rare: The EU must take this opportunity to effect...
Revision of the OMP Regulation holds opportunities for improving the lives of those living with a rare disease.
A call to action: Addressing inequalities between European healthcare systems
We must rethink the structure of healthcare systems and workforce strategies across the EU and address geographic disparities of healthcare professionals.
Defence Therapeutics granted US patent for vaccine enhancer technology
Discover how the issue of a patent will allow Defence Therapeutics' vaccine enhancer technology to be commercialised.
European Patients’ Rights Day and ATMPs: Combining sustainability, innovation and respect for patients’ rights
Mariano Votta and Bianca Ferraiolo from the Cittadinanzattiva-Active Citizenship Network discuss this year’s European Patients’ Rights Day which focuses on Advanced Therapy Medicinal Products...